Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity,...
Main Author: | Dimitri Poddighe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118219300489 |
Similar Items
-
Is there any relationship between extra-pulmonary manifestations of Mycoplasma pneumoniae infection and atopy/respiratory allergy in children?
by: Dimitri Poddighe, et al.
Published: (2016-03-01) -
Increased Total Serum Immunoglobulin E in Children Developing Mycoplasma pneumoniae-related Extra-pulmonary Diseases
by: Dimitri Poddighe, et al.
Published: (2018-10-01) -
Rhabdomyolysis Associated with Antimicrobial Drug–Resistant Mycoplasma pneumoniae
by: Tomohiro Oishi, et al.
Published: (2012-05-01) -
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01) -
Autoimmune pulmonary alveolar proteinosis mimicking Mycoplasma pneumonia in an adolescent
by: Shaiva Ginoya Meka, et al.
Published: (2020-01-01)